Following Brexit, the Medicines and Healthcare Regularoty Agency (MHRA) has become the UK's sole bod...
Read moreThis study aimed to assess whether the new process has resulted in changes to outcomes of STAs.
Read moreThis study aimed to review timelines and use of financial agreements for products being appraised.
Read moreA recent study assessed whether this new process has resulted in faster patient access.
Read more... and the use of financial arrangements for new oncology and non-oncology drugs?
Read moreICER’s Health Technology Assessments review process is an assessment undertaken by one of three ap...
Read moreThis newsletter will discuss the early access processes operating within the UK and discuss the adva...
Read moreHow has the data available within NCRAS been utilized within the CDF overseen by NICE, in partnershi...
Read moreNICE has decided to adapt the technical engagement step in a hope to improve stakeholder inclusion, ...
Read moreNICE has announced they will begin a phased restart of publishing guidance, whilst SMC meetings are ...
Read more